Mereo Capital Partners and Hyperion Capital Partners have acquired Algus Packaging (Algus), a provider of thermoformed blister and clamshell packaging and manufacturer of blister seal machines. 

Private equity firm Bridgepoint Group has made a £400 million bid to acquire a 75% stake in English cricket’s the Hundred, the newest short-form version of the sport launched by the England and Wales Cricket Board (ECB), according to a report by Sky News. The proposal by the London-listed buyout

KKR Group is to become the majority shareholder in the APRIL group, one of Europe’s leading insurance brokerages which was previously backed by CVC Capital Partners.

Mediterrania Capital Partners, a private equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, is set to make its sixth portfolio company exit in 12 months with the approval from AMMC, the Moroccan Capital Market Authority, for an IPO of Akdital Group

Abris Capital Partners, a specialist private equity investor focused on the ESG transformation, has supported Scanmed, a Polish healthcare business, in acquiring Ars Medical, a specialist in cancer care treatment in Poland.

FogPharma, a Cambridge, Masachussetts-based biopharmaceutical company developing helicon polypeptides, has raised $178 million in a Series D funding round.  The round includes new investors ARCH Venture Partners, Milky Way Investments, Fidelity Management & Research Company, and existing investors VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, T Rowe Price Associates,

Alchemy has sold one of Italy’s leading providers of portable sanitary solutions, YLDA, to Germany-based trade buyer Toi Toi & Dixi Group, a business which has been owned by Apax Partners since 2019. The transaction has resulted in a 4x MM return for Alchemy. YLDA is a Tuscany-based specialist in